National Center for Complementary and Integrative Health (NCCIH)

NIH…Turning Discovery Into Health

Follow NCCIH Subscribe to our email update Subscribe to the NCCIH RSS feed Follow NCCIH on FacebookRead our disclaimer about external links Follow NCCIH on TwitterRead our disclaimer about external links

Menu

Past Blog Posts

N C C A M Research Blog

Past Blog Posts

January 24, 2014
D. Craig Hopp, Ph.D.
D. Craig Hopp, Ph.D.

I have an exciting new funding opportunity announcement (FOA) to tell you about: the “Center for Advancing Natural Products Innovation and Technology (U41),” or RFA-AT-14-006. This grant is part of a diverse portfolio of projects on natural products research cosponsored by NCCAM and the NIH Office of Dietary Supplements (ODS). The goal of this FOA is to improve upon and strengthen the technologies and methods used in natural-products research—leading to better understanding of the biology and chemistry of natural products and how they impact health and wellness.

Read more »

January 02, 2014
Josephine P. Briggs, M.D.
Josephine P. Briggs, M.D.

“Pragmatic trials” are the new buzz in clinical research. I want to spend this post talking a bit about why—and the reasons for NCCAM’s particular interest in this topic.

Read more »

December 17, 2013
Linda Duffy, Ph.D., M.P.H.
Linda Duffy, Ph.D.

On September 9, NCCAM was pleased to host Patricia Hibberd, M.D., Ph.D., who delivered a lecture at NIH on “Probiotics, the Microbiome, and Host Immune Response: Insights for Novel Therapeutic Approaches.” Dr. Hibberd is professor of pediatrics at Harvard Medical School, and chief of the Division of Global Health at Massachusetts General Hospital for Children, as well as professor of global health at Harvard School of Public Health.

Read more »

December 09, 2013
Josephine P. Briggs, M.D.
Josephine P. Briggs, M.D.

A recent study in the New England Journal of Medicine, authored by six researchers at the National Heart, Lung, and Blood Institute (NHLBI), prompts some thoughts about studies with negative outcomes—and their importance in the entire research process.

Read more »

November 21, 2013
Josephine P. Briggs, M.D.
Josephine P. Briggs, M.D.

Earlier this week, a new secondary analysis of results of the Trial to Assess Chelation Therapy (TACT) was published in the journal Circulation: Cardiovascular Quality & Outcomes and presented at the American Heart Association meeting. The analysis suggests that the EDTA-based chelation treatments produced a marked reduction in cardiovascular events and death in participants with diabetes. Furthermore, the results suggest that treatments had no benefit in those who did not have diabetes.

Read more »

Pages